Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes

被引:107
作者
Bramlett, KS [1 ]
Wu, YF [1 ]
Burris, TP [1 ]
机构
[1] Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
关键词
D O I
10.1210/me.15.6.909
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nuclear receptors (NRs) require coactivators to efficiently activate transcription of their target genes. Many coactivators including the p160 proteins utilize a short NR box motif to recognize the ligand-binding domain of the NR when it is activated by ligand. To investigate the ability of various ligands to specify the affinity of NR boxes for a ligand-bound NR, we compared the capacity of p160 NR boxes to be recruited to estrogen receptor (ER alpha) and ER beta in the presence of 17 beta -estradiol, diethylstilbestrol, and genestein. A time-resolved fluorescence-based binding assay was used to determine the dissociation constants for the 10 NR boxes derived from the three p160 coactivators for both ER subtypes in the presence of the each of the agonists. While the affinity of some NR boxes for ER was independent of the agonist, we identified several NR boxes that had significantly different affinities for ER depending on which agonist was bound to the receptor. Therefore, an agonist may specify the affinity of an NR for various NR boxes and thus regulate the coactivator selectivity of the receptor.
引用
收藏
页码:909 / 922
页数:14
相关论文
共 72 条
[1]   A NOVEL VITAMIN-D3 ANALOG, 22-OXA-1,25-DIHYDROXYVITAMIN-D3, INHIBITS THE GROWTH OF HUMAN BREAST-CANCER INVITRO AND INVIVO WITHOUT CAUSING HYPERCALCEMIA [J].
ABE, J ;
NAKANO, T ;
NISHII, Y ;
MATSUMOTO, T ;
OGATA, E ;
IKEDA, K .
ENDOCRINOLOGY, 1991, 129 (02) :832-837
[2]   An ultrahigh-throughput screening assay for estrogen receptor ligands [J].
Allan, GF ;
Hutchins, A ;
Clancy, J .
ANALYTICAL BIOCHEMISTRY, 1999, 275 (02) :243-247
[3]   AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer [J].
Anzick, SL ;
Kononen, J ;
Walker, RL ;
Azorsa, DO ;
Tanner, MM ;
Guan, XY ;
Sauter, G ;
Kallioniemi, OP ;
Trent, JM ;
Meltzer, PS .
SCIENCE, 1997, 277 (5328) :965-968
[4]   Differential response of estrogen receptor α and estrogen receptor β to partial estrogen agonists/antagonists [J].
Barkhem, T ;
Carlsson, B ;
Nilsson, Y ;
Enmark, E ;
Gustafsson, JÅ ;
Nilsson, S .
MOLECULAR PHARMACOLOGY, 1998, 54 (01) :105-112
[5]   Molecular basis of agonism and antagonism in the oestrogen receptor [J].
Brzozowski, AM ;
Pike, ACW ;
Dauter, Z ;
Hubbard, RE ;
Bonn, T ;
Engstrom, O ;
Ohman, L ;
Greene, GL ;
Gustafsson, JA ;
Carlquist, M .
NATURE, 1997, 389 (6652) :753-758
[6]  
BURRIS TP, 2000, NUCL RECEPTORS GENET, P1
[7]   Cloning and characterization of RAP250, a novel nuclear receptor coactivator [J].
Caira, F ;
Antonson, P ;
Pelto-Huikko, M ;
Treuter, E ;
Gustafsson, JÅ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (08) :5308-5317
[8]  
Chang CY, 1999, MOL CELL BIOL, V19, P8226
[9]   Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300 [J].
Chen, HW ;
Lin, RJ ;
Schiltz, RL ;
Chakravarti, D ;
Nash, A ;
Nagy, L ;
Privalsky, ML ;
Nakatani, Y ;
Evans, RM .
CELL, 1997, 90 (03) :569-580
[10]   Coactivation and corepression in transcriptional regulation by steroid/nuclear hormone receptors [J].
Chen, JD ;
Li, H .
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 1998, 8 (02) :169-190